DexCom (DXCM)
DexCom Enterprise Value: 724.61M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
DXCM Enterprise Value Rankings
| Overall | 49th percentile | 2166 of 4266 |
| Sector | 65th percentile | 171 of 493 in Healthcare |
| Industry | 60th percentile | 25 of 64 in Medical Instruments & Supplies |
DXCM Enterprise Value Range, Past 5 Years
| Minimum | 113.25M | Dec 2008 |
| Maximum | 961.99M | Mar 2011 |
| Average | 496.64M |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
You may also be interested in these DXCM related companies
DXCM News
Listen to $DXCM at deutsche bank ag health care conference - live at 09:20 AM, ondemand after - http://stks.co/3iYr
about 21 days ago by earningscast
about 21 days ago by earningscast
Canaccord Genuity Maintains a 'Buy' on DexCom (DXCM); Gen 4 in FDA's Hands Now
May 03, 9:54AM Street Insider
May 03, 9:54AM Street Insider
Dexcom to Present at the Deutsche Bank 37th Annual Healthcare Conference
Apr 26, 8:30AM Business Wire
Apr 26, 8:30AM Business Wire
Dexcom Schedules First Quarter 2012 Earnings Release and Conference Call for May 2, 2012
Apr 25, 8:30AM Business Wire
Apr 25, 8:30AM Business Wire
Leerink Swann Starts DexCom (DXCM) at Market Perform; Positive Long-Term, But Some Near-Term Hurdles
Apr 02, 7:52AM Street Insider
Apr 02, 7:52AM Street Insider
$DXCM forms bullish "Continuation Wedge" chart pattern. http://stks.co/2tRo
about 74 days ago by RecogniaEvents
about 74 days ago by RecogniaEvents
Canaccord Genuity Reiterates a 'Buy' on DexCom (DXCM); Solid Q4 & Conservative Guidance
Feb 24, 10:40AM Street Insider
Feb 24, 10:40AM Street Insider
Brean Murray Carret Raises Price Target on DexCom (DXCM), Strong Potential with Gen4 and SweetSpot
Feb 24, 10:18AM Street Insider
Feb 24, 10:18AM Street Insider
RT @ChartSwingTrade Potential earning movers tomorrow based on charts - $BOOM $UEIC $DXCM $AXTI $OVTI $SD Many earnings moves today faded
about 95 days ago by 1973Hog
about 95 days ago by 1973Hog
Listen to $DXCM Q4 2011 earnings call - live at 04:30 PM, ondemand after - http://stks.co/2XOD
about 95 days ago by earningscast
about 95 days ago by earningscast
$DXCM Reports Q4 EPS $(0.18) vs $(0.17) Est; Revenues $22.40M vs $21.63M Est
about 95 days ago by Benzinga
about 95 days ago by Benzinga
DexCom, Inc. Reports Fourth Quarter and Full Year 2011 Financial Results
Feb 23, 4:05PM Business Wire
Feb 23, 4:05PM Business Wire
Dexcom Schedules Fourth Quarter and Full Year 2011 Earnings Release and Conference Call for February 23, 2012
Feb 14, 9:05AM Business Wire
Feb 14, 9:05AM Business Wire
Canaccord Genuity on Life Sciences/Biomedical Devices and Services: Take on Q4 and Beyond
Feb 07, 8:39AM Street Insider
Feb 07, 8:39AM Street Insider
DexCom and Tandem Diabetes Care Announce CGM Development and Commercialization Agreement
Feb 02, 8:30AM Business Wire
Feb 02, 8:30AM Business Wire
...would not hurt them if the market pulls back a bit here. The patterns look very good however. $ACOM $DXCM $CROX $STMP
about 132 days ago by ChartSwingTrade
about 132 days ago by ChartSwingTrade
$ACOM $DXCM $CROX $STMP - all forming VERY nice flag patterns here and are probably my favorite candidates this week. A little more rest...
about 132 days ago by ChartSwingTrade
about 132 days ago by ChartSwingTrade
Brean Murray Carret & Co. Starts DexCom (DXCM) at Buy; Sensing a Better Year Ahead
Jan 17, 7:30AM Street Insider
Jan 17, 7:30AM Street Insider
All I want for the New Year is for most of my daily charts to look like $DXCM, what a lovely thing.
about 151 days ago by jstajrk2
about 151 days ago by jstajrk2
$DXCM http://stks.co/1iMQ from watch list is into the gap but vol so far only 23% of ave full day
about 152 days ago by StockTiger
about 152 days ago by StockTiger
$DXCM http://stks.co/1eRW 50-day is at $8.75 so over that on good volume
about 159 days ago by StockTiger
about 159 days ago by StockTiger
$DXCM http://stks.co/1da1 Nice move yest on +volume. Sitting on 50d and top of recent range.
about 160 days ago by TER_Intraday
about 160 days ago by TER_Intraday
EBR Watchlist/worksheet/3 Trading Ideas: $GOOG $VCHC $TZOO $GMCR $DXCM http://stks.co/1dZo
about 160 days ago by TER_Intraday
about 160 days ago by TER_Intraday
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| DXCM | 10.79 | +0.30 | +2.86% | 729.73M |
| DX | 9.35 | +0.03 | +0.32% | 506.02M |
| DWX | 42.82 | -0.02 | -0.05% | |
| DWSN | 24.95 | +0.07 | +0.28% | 197.60M |
| DSX | 8.25 | +0.27 | +3.38% | 681.20M |
| DSW | 61.17 | -0.22 | -0.36% | 2.682B |
| DSUM | 23.85 | -0.03 | -0.13% | |
| DSU | 4.12 | +0.10 | +2.49% | |
| DSTI | 1.09 | +0.08 | +7.92% | 1.504M |
| DST | 51.79 | -0.68 | -1.30% | 2.307B |
